Measurement of tumor blood flow using dynamic contrast-enhanced magnetic resonance imaging and deconvolution analysis: A preliminary study in musculoskeletal tumors

Journal of Computer Assisted Tomography

Volumn 30, Issue 6, 2006, Pages 983-990

  Sugawara, Yoshifumi ^a   Murase, Kenya ^b   Kikuchi, Keiichi ^a   Sakayama, Kenshi ^a   Miyazaki, Tatsuhiko ^a   Kajihara, Makoto ^a   Miki, Hitoshi ^a   Mochizuki, Teruhito ^a  

^a EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

MRI; Musculoskeletal tumor; Treatment response; Tumor blood flow

Indexed keywords

BLOOD; CHEMOTHERAPY; GADOLINIUM; HEMODYNAMICS; MUSCLE; PIXELS; TUMORS;

BLOOD FLOW; DECONVOLUTION ANALYSIS; DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE IMAGING; GADOLINIA; IMAGING ANALYSIS; MEASUREMENTS OF; MUSCULOSKELETAL TUMORS; SIGNAL INTENSITIES; TREATMENT RESPONSE; TUMOR BLOOD FLOWS;

MAGNETIC RESONANCE IMAGING;

GADOLINIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD FLOWMETRY; BONE TUMOR; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIPOSARCOMA; MALE; MUSCLE BLOOD FLOW; MUSCLE TUMOR; MUSCULOSKELETAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR BLOOD FLOW;

EID: 33750708617     PISSN: 03638715     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.rct.0000232475.07163.19     Document Type: Article

References (27)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med. 1971;285:1182-1186.
2. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med. 1991;324:1-8.
3. Wiggins DL, Granai CO, Steinhoff MM, et al. Tumor angiogenesis as a prognostic factor in cervical carcinoma. Gynecol Oncol. 1995;56:353-356.
4. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol. 1995;13:765-782.
5. Folkman J. New perspectives in clinical oncology from angiogenesis research. Eur J Cancer. 1996;32A:2534-2539.
6. Pluda JM. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin Oncol. 1997;24:203-218.
7. Delorme S, Knopp MV. Non-invasive vascular imaging: assessing tumour vascularity. Eur Radiol. 1998;8:517-527.
8. Anderson H, Price P. Clinical measurement of blood flow in tumours using positron emission tomography: a review. Nucl Med Commun. 2002;23:131-138.
9. Ruotsalainen U, Raitakari M, Nuutila P, et al. Quantitative blood flow measurement of skeletal muscle using oxygen-15-water and PET. J Nucl Med. 1997;38:314-319.
10. Tofts PS, Kermode AG. Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med. 1991;17:357-367.
11. Brix G, Semmler W, Port R, et al. Pharmacokinetic parameters in CNS Gd-DTPA enhanced MR imaging. J Comput Assist Tomogr. 1991;15:621-628.
12. Ostergaard L, Weisskoff RM, Chesler DA, et al. High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: mathematical approach and statistical analysis. Magn Reson Med. 1996;36:715-725.
13. Pahernik S, Griebel J, Botzlar A, et al. Quantitative imaging of tumour blood flow by contrast-enhanced magnetic resonance imaging. Br J Cancer. 2001;85:1655-1663.
14. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol. 1954;6:731-744.
15. Rosen G, Caparros B, Huvos AG, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49:1221-1230.
16. Murase K, Kikuchi K, Miki H, et al. Determination of arterial input function using fuzzy clustering for quantification of cerebral blood flow with dynamic susceptibility contrast-enhanced MR imaging. J Magn Reson Imaging. 2001;13:797-806.
17. Fritz-Hansen T, Rostrup E, Larsson HB, et al. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med. 1996;36:225-231.
18. Kikuchi K, Murase K, Miki H, et al. Quantitative evaluation of mean transit times obtained with dynamic susceptibility contrast-enhanced MR imaging and with (133)Xe SPECT in occlusive cerebrovascular disease. AJR Am J Roentgenol. 2002;179:229-235.
19. Ohno Y, Hatabu H, Murase K, et al. Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging. 2004;20:353-365.
20. Purdie TG, Henderson E, Lee TY. Functional CT imaging of angiogenesis in rabbit VX2 soft-tissue tumour. Phys Med Biol. 2001;46:3161-3175.
21. Hudlicka O. Regulation of muscle blood flow. Clin Physiol. 1985;5:201-229.
22. Verstraete KL, De Deene Y, Roels H, et al. Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging-parametric "first-pass" images depict tissue vascularization and perfusion. Radiology. 1994;192:835-843.
23. van der Woude HJ, Bloem JL, Verstraete KL, et al. Osteosarcoma and Ewing's sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable tumor before surgery. AJR Am J Roentgenol. 1995;165:593-598.
24. Verstraete KL, Van der Woude HJ, Hogendoorn PC, et al. Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications. J Magn Reson Imaging. 1996;6:311-321.
25. Dyke JP, Panicek DM, Healey JH, et al. Osteogenic and Ewing sarcomas: estimation of necrotic fraction during induction chemotherapy with dynamic contrast-enhanced MR imaging. Radiology. 2003;228:271-278.
26. Erlemann R, Sciuk J, Bosse A, et al. Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology. 1990;175:791-796.
27. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology. 1996;200:639-649.